Mondaq News Alerts (registration) Novartis is the proprietor of two European patents ("the patents") relating to the treatment of osteoporosis, together with an earlier patent and supplementary protection certificate ("SPC") covering zoledronic acid and in force until 15 May 2013 ...
Nanowerk ("New self-assembly nanoparticles and stealth liposomes for the delivery of zoledronic acid : a comparative study") who used no less than three administrations per week of liposomes encapsulating Zoledronic acid and exceeded the effect achieved by a ...
dailyRx For this study, Emma J. Rathbone, PhD, of the Academic Unit of Clinical Oncology at Weston Park Hospital in Sheffield, England, and colleagues looked at the frequency of ONJ in cancer survivors taking zoledronic acid and overall oral health-related ...
Lexology (registration) Hospira sought revocation of two Novartis patents that related to the treatment of osteoporosis by the administration of zoledronic acid or zoledronate (a zoledronic acid salt) intravenously at intervals of at least six months. On 15 March 2013, Arnold ...
OncLive This agent is administered subcutaneously, does not require renal monitoring, and was shown to be more effective than zoledronic acid in clinical trials. Since its approval, denosumab has been incorporated into many treatment paradigms and bone health ...
Cancer Network The use of bisphosphonate therapy (mostly zoledronic acid (Drug information on zoledronic acid )) in patients with metastasis of the bone did not improve either progression-free survival or overall survival. No patient in the pooled cohort received ...
Patent Docs Hospira, a generics company, started revocation actions against these two patents and obtained a marketing authorisation for zoledronic acid to treat a number of conditions, including osteoporosis. Soon after becoming aware of the marketing ...
Herald & Review Zoledronic acid (Reclast) is a medicine that works the same way as Fosamax and Actonel, but is given via a once-yearly injection, which makes it a good choice for people with reflux problems. An alternative is Forteo (terapartide), which works in a ... and more »
Valley News Zoledronic acid (Reclast) is a medicine that works the same way as Fosamax and Actonel, but is given via a once-yearly injection, which makes it a good choice for people with reflux problems. An alternative is Forteo (terapartide), which works in a ... and more »
